Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Priming the hematopoietic pump.

Stuart H Orkin1

  • 1Dana Farber Cancer Institute and Children's Hospital, Harvard Medical School, Howard Hughes Medical Institute, Boston, MA 02115, USA.

Immunity
|November 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Medicine - Primed and Ready.

The New England journal of medicine·2026
Same author

The Fetal-to-Adult Hemoglobin Switch - Mechanism and Therapy.

The New England journal of medicine·2025
Same author

Redirecting E3 ubiquitin ligases for targeted protein degradation with heterologous recognition domains.

The Journal of biological chemistry·2024
Same author

Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells.

Cell stem cell·2024
Same author

A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing.

Science (New York, N.Y.)·2024
Same author

Structural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6.

Structure (London, England : 1993)·2024
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
Same journal

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

Immunity·2026
Same journal

The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy.

Immunity·2026
Same journal

Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infection.

Immunity·2026
Same journal

Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes.

Immunity·2026
See all related articles

Hematopoietic stem cells exhibit "promiscuous" gene expression, showing markers of multiple cell types. This lineage priming does not hinder their ability to regenerate blood over the long term.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Multipotent progenitors in hematopoiesis express markers of multiple lineages, a state termed lineage priming.
  • This phenomenon suggests a degree of "promiscuous" gene expression in early blood development.

Discussion:

  • The study investigates whether lineage priming is also present in hematopoietic stem cells (HSCs).
  • It examines the functional consequences of this promiscuous gene expression on HSC function.

Key Insights:

  • Hematopoietic stem cells (HSCs) demonstrate lineage priming, expressing markers typically associated with multiple differentiated blood cell types.
  • This promiscuous gene expression in HSCs does not compromise their critical long-term hematopoietic repopulation potential.

Related Experiment Videos

Outlook:

  • Understanding lineage priming in HSCs offers insights into stem cell regulation and differentiation.
  • Further research may explore the regulatory mechanisms governing promiscuous gene expression and its role in maintaining stem cell identity and function.